A pilot study of trastuzumab monotherapy in patients who progressed under a previous platinum-based or 5-fluoropyrimidin-based chemotherapy in metastatic or locally advanced gastric cancer

Mise à jour : Il y a 5 ans
Référence : EUCTR2005-001220-37

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

to determine the response rate (CR + PR) according to RECIST criteria


Critère d'inclusion

  • Metastatic or locally advanced gastric cancer (stage IV) with HER2 overexpression

Liens